Results 151 to 160 of about 297,952 (346)

Evaluation of targeted next‐generation sequencing for detection of HPV genotypes and sublineages in cervical liquid‐based cytology SurePath samples from the Danish screening program

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Human papillomavirus (HPV) assays currently used in cervical cancer screening detect genotypes without providing information on viral lineages and sublineages. However, genotype‐specific sublineages may have distinct risk profiles, which could be harnessed to further improve risk stratification.
Karoline Andersen   +8 more
wiley   +1 more source

The prognostic value of cell‐free DNA dynamics during chemoradiotherapy in squamous cell carcinomas of the anus

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Chemoradiotherapy is the standard treatment for squamous cell carcinoma of the anus (SCCA). Toxicities linked to chemoradiotherapy, however, can negatively impact the quality of life, and biomarkers to distinguish which patients will benefit from treatment are lacking.
Anne Vittrup Jakobsen   +4 more
wiley   +1 more source

Under which realistic circumstances is hrHPV self‐sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Offering the option of self‐sampling in cervical cancer screening programs could increase participation. However, it could also prompt participants to switch from clinician‐collecting sampling, which has demonstrated higher testing sensitivity and lower loss to follow‐up.
Sylvia Kaljouw   +4 more
wiley   +1 more source

The Impact of HPV Vaccination on Cervical Cancer in adolescent females: A narrative review

open access: yesJournal of Family Medicine and Primary Care
To effectively prevent cervical cancer, a leading cause of global morbidity and mortality among women, widespread adoption of the HPV vaccine has a well-established link to human papillomavirus (HPV) infection.
Vijay Bhalerao   +2 more
doaj   +1 more source

Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)‐associated tonsillar squamous cell carcinoma (TSCC)

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Human papillomavirus (HPV)‐associated tonsillar squamous cell carcinoma (TSCC) is suspected of originating from tonsillar crypts, where HPV can persist in latent form. Detection is further complicated by the possible absence of premalignant stages, namely carcinoma in situ (CIS). Here, the authors investigated tumor origin in HPV‐associated
Tobias Näsman   +3 more
wiley   +1 more source

The effect of making a ‘third dose assumption’ on HPV coverage estimates

open access: yesAustralian and New Zealand Journal of Public Health, 2015
Julia M. Brotherton, Karen Winch
doaj   +1 more source

IAPSM’s Position Paper on the Human Papilloma Virus (HPV) Vaccine for Adult Immunization in India

open access: yesIndian Journal of Community Medicine
Cervical cancer ranks as the second most common cancer in women in India, primarily caused by persistent infection with the human papillomavirus (HPV). Given its long latent period, secondary prevention through screening and early detection is essential.
Ranjitha S. Shetty   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy